MYC and breast cancer: In cisplatin-resistant BC cells, up-regulated oncogene transcription factors c-MYC, OCT4 and p53 can be enriched in the NEAT1 promoter region and activate its transcription, inhibit apoptosis, and promote cisplatin resistance in BC cells [58].